Predicting heart outcomes after birth for babies with pulmonary atresia and intact ventricular septum
Builds a model predicting after-birth heart circulation in fetuses with pulmonary atresia or critical stenosis.
Key facts
- Who runs it
- Hospital Universitario 12 de Octubre
- Where
- Spain and Sweden2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Registry title
- Prognostic Model of Postnatal Circulation in Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 1 Feb 2024
- Expected to end
- 31 Dec 2029
- Type of study
- Observational, 2 groups
- Record updated
- 15 September 2025
Who can take part
The trial is looking for unborn babies (fetuses) found before birth to have pulmonary atresia or critical stenosis with an intact ventricular septum. It only observes them and gives no treatment.
- Age
- Fetuses at 16 Weeks to 28 Weeks
- Sex
- All
- Disease stage
- No blood flow through the pulmonary valve, or a thick, domed valve with only a pinhole jet of flow. Blood flow to the lungs depends on the ductus (a blood vessel open before birth). The wall between the heart's lower chambers is intact.
- Earlier treatment
- Cases that later have a balloon procedure to open the pulmonary valve before birth (prenatal pulmonary valvuloplasty) are removed from the trial.
- Biomarker or test result
- Doppler ultrasound shows that blood flow to the lungs depends on the ductus.
- Main reasons for not taking part
- Poor quality or incomplete ultrasound scan
- Termination of the pregnancy
- Diagnosis not confirmed at birth, or functional forms such as Ebstein malformation or monochorionic twins
- Any other heart defect, except persistent left superior vena cava and aberrant right subclavian artery
- Any important problem outside the heart or a known genetic syndrome, even if found only after birth
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Absence of flow at the pulmonary valve (PA) or presence of thickened and domed. pulmonary valve cusps with a pinhole jet of flow
- Doppler evidence of ductal-dependent pulmonary circulation
- Intact ventricular septum
Who cannot take part
- Any associated cardiac defect except persistent left superior vena cava and aberrant right subclavian artery
- Any significant (i.e that might influence outcome) extracardiac anomaly and/or known genetic syndromes. Also, if such a condition is present at inclusion but diagnosed only after birth, the case will be retrospectively excluded
- Poor imaging windows and incomplete/poor quality scan
- Termination of pregnancy
- Cases initially included that undergo prenatal pulmonary valvuloplasty later on in pregnancy
- Unconfirmed PA-CS/IVS at birth
- Functional PA-CS/IVS (Ebstein malformation, monochorionic twins)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Congenital heart disease or fetal cardiac disorder
This trial is currently available in Spain.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pulmonary atresia (PA)/critical stenosis (CS) with intact ventricular septum (PA/CS-IVS) is a rare congenital heart disease (CHD), that presents heterogeneously. Prognosis is conditioned by the possibility of achieving a primary repair with biventricular circulation (BV) or a one-and-a-half ventricle solution vs. a palliative approach bound to a univentricular (UV) circulation in which both survival and quality of life are significantly impaired. Predicting UV circulation prenatally is still a challenge.
Read full original descriptionShow less
The aim of this study is: 1/ to evaluate the natural history of the disease and develop a prognostic model for the prediction of transplantation-free survival with a biventricular or a one-and-a-half repair at 2 years postnatal age 2/ To develop a model to predict the risk of right ventricle dependent coronary circulation 3/ To evaluate prenatal and postnatal outcomes in non-intervened fetuses with a confirmed postnatal diagnosis of PA-CS/IVS including Intrauterine death, neonatal/Infant death, number of required postnatal procedures, need for oxygen support, need for cardiac transplantation
The 2 groups in the trial
- Retrospective cohort
Retrospective cases that meet all the inclusion criteria and none of the exclusion criteria from 2013 until 2023 will be included for model development. They should be non-intervened cases in order to assess the natural history of the disease.
- Prospective cohort
Prospectively recruited cases will be included when meeting all the inclusion criteria and none of the exclusion ones. This cohort will serve as a validation cohort for the previously developed model. The nature of the study is observational. Clinicians will not be given the result of the model during the study and clinical practice will be routine.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Development and Validation of a Prognostic Model of Postnatal Circulation in Fetuses With a Diagnosis of Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum A Prospective Observational Cohort Study
- Plain-language title
- Predicting heart outcomes after birth for babies with pulmonary atresia and intact ventricular septumGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07095829, who can take part
- Publications
- Record updated
- 15 September 2025